期刊文献+

糖尿病血管并发症的相关机制及糖被的作用 被引量:4

Related mechanisms of vascular complications in diabetes and the role of glycocalyx layer
下载PDF
导出
摘要 糖尿病是由胰岛素相对或绝对不足所导致的糖、脂肪及蛋白质的代谢紊乱。糖尿病血管并发症是糖尿病患者致死致残的主要原因。近期研究显示糖被有可能作为内皮细胞剪切力感受器而在血管保护中起至关重要的作用。在糖尿病血管病变中,内皮细胞上附着的糖被存在大量被破坏的现象,通过药物等方式恢复糖被有助于糖尿病并发症的缓解。因此,文章主要讲述糖尿病血管并发症的各种机制,侧重于讲述糖被在糖尿病血管并发症中的作用。 Diabetes is a metabolic disorder of glucose,fat,and protein caused by relative or absolute lack of insulin.Diabetic vascular complications are the main cause of death and disability in patients with diabetes.Recent studies have shown that the glycocalyx layer may play as a vital role in vascular protection as an endothelial cell shear receptor.In diabetic vascular complications,the glycocalyx layer attached to endothelial cells is found to have substantial destruction,and restoring the glycocalyx layer by drugs and other ways contributes to the relief of diabetic complications.Therefore,this article mainly describes the various mechanisms of diabetic vascular complications,with an emphasis on the role of the glycocalyx layer in diabetic vascular complications.
作者 陈熠雯 夏淑东 CHEN Yiwen;XIA Shudong(The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu 322000, China)
出处 《邵阳学院学报(自然科学版)》 2021年第5期109-116,共8页 Journal of Shaoyang University:Natural Science Edition
基金 金华市科技局课题(20203010)。
关键词 糖尿病 血管并发症 内皮损伤 糖被 diabetes vascular complication endothelial injury glycocalyx layer
  • 相关文献

参考文献2

二级参考文献50

  • 1Unger T, Culman J, Gohlke P. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence. J Hypertens 1998; 16 (Suppl 7): S3-9.
  • 2Zimpelmann J, Kumar D, Levine DZ, Wehbi G, Imig JD, Navar LG, et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int 2000; 58: 2320- 30.
  • 3Wehbi GJ, Zimpelmann J, Carey RM, Levine DZ, Burns KD. Early streptozotocin-diabetes mellitus downregulates rat kidney AT(2) receptors. Am J Physiol Renal Fluid Electrolyte Physiol 2001; 280: F254-65.
  • 4Gilbert RE, Cox A, Wu LL, Allen T J, Hulthen L, Jerums G, et al. Expression of transforming growth factor-β1 and type Ⅳ col- lagen in the renal tubulointerstitium in experimental diabetes: effects of angiotensin converting enzyme inhibition. Diabetes 1998; 47: 414-22.
  • 5Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-9.
  • 6Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB,et al. Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851-60
  • 7Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin Ⅰ to angiotensin 1-9. Circ Res 2000; 87: E1-9.
  • 8Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238--43.
  • 9Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277:14 838-43.
  • 10Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002; 532: 107-10.

共引文献14

同被引文献35

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部